Evaluating Consolidative Thoracic Radiotherapy with Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: Insights from the Phase 2 TREASURE Trial
Posted innews Oncology Respiratory

Evaluating Consolidative Thoracic Radiotherapy with Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: Insights from the Phase 2 TREASURE Trial

The Phase 2 TREASURE trial investigated the safety and efficacy of adding consolidative thoracic radiotherapy to atezolizumab maintenance in extensive-stage small cell lung cancer, revealing increased toxicity without survival benefit, underscoring the need for cautious patient selection.
Safety and Efficacy of Staged, Bilateral MRgFUS Pallidothalamic Tractotomy in Parkinson’s Disease Motor Complications: A Contemporary Evidence Review
Posted inClinical Updates Neurology news

Safety and Efficacy of Staged, Bilateral MRgFUS Pallidothalamic Tractotomy in Parkinson’s Disease Motor Complications: A Contemporary Evidence Review

This review synthesizes evidence on staged, bilateral MRgFUS pallidothalamic tractotomy for Parkinson's motor complications, highlighting demonstrated unilateral safety and modest bilateral efficacy with increased adverse events, underscoring critical patient selection.
Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial Infarction: The APERITIF Randomized Clinical Trial
Posted inCardiology news

Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial Infarction: The APERITIF Randomized Clinical Trial

The APERITIF trial explored adding low-dose rivaroxaban to standard dual antiplatelet therapy to prevent heart clots after an anterior heart attack. While the addition did not significantly reduce thrombus formation, it did increase minor bleeding risk, suggesting a need for cautious clinical application.